While small still, pharmacoproteomics may shed some light on even more of the reasons drugs work differently on different people and help us make more people well.
Researchers at Avera Health are in the process of developing the GenFolio, a comprehensive searchable encyclopaedia.
The US Department of Justice made an example out of a clinic that failed that remain honest and transparent regarding the whereabouts of its money.
Some cannabis enthusiasts in Canada are claiming that they can harness the work that pharmacogenomicists have done in the past 50 years or so to tailor strains of the plant to certain genomic characteristics.
Integration of pharmacogenomics in routine health care will need a lot of further research, but 2018 could mark the beginning of a more systematic approach towards design and development of new medicines based on genomics.
The researchers are hoping to be able to implement some of their findings as early as 2018 to reign in the crisis and help deliver the right dosage to the right patient.
Ending the opioid epidemic is up to all of us. Encourage your friends and family members to turn in unused prescriptions and keep them out of the wrong hands.
It’s a huge step for pharmacogenomics that we can correlate reactions to the same drug with the same genetic underpinnings.
We have to start harnessing all the data we have towards finding more effective solutions to problems as common as blood pressure, and this study could be a huge first step.